Gastroduodenal safety and tolerability of lumiracoxib compared with ibuprofen and celecoxib in patients with osteoarthritisHAWKEY, Christopher C; SVOBODA, Petr; FIEDOROWICZ-FABRYCY, Irena F et al.Journal of rheumatology. 2004, Vol 31, Num 9, pp 1804-1810, issn 0315-162X, 7 p.Article

Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy StudyGENOVESE, Mark C; MCKAY, James D; NASONOV, Evgeny L et al.Arthritis and rheumatism. 2008, Vol 58, Num 10, pp 2968-2980, issn 0004-3591, 13 p.Article